SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019101
Filing Date
2016-05-11
Accepted
2016-05-11 16:11:05
Documents
38
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20160331.htm 10-Q 661434
2 EX-31.1 evok-ex311_35.htm EX-31.1 9579
3 EX-31.2 evok-ex312_37.htm EX-31.2 9851
4 EX-32.1 evok-ex321_38.htm EX-32.1 5021
5 EX-32.2 evok-ex322_36.htm EX-32.2 5152
  Complete submission text file 0001564590-16-019101.txt   2297381

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evok-20160331.xml EX-101.INS 345739
7 XBRL TAXONOMY EXTENSION SCHEMA evok-20160331.xsd EX-101.SCH 25850
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20160331_cal.xml EX-101.CAL 15942
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20160331_def.xml EX-101.DEF 81378
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20160331_lab.xml EX-101.LAB 194300
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20160331_pre.xml EX-101.PRE 135213
Mailing Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE DRIVE SUITE 270 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 161640000
SIC: 2834 Pharmaceutical Preparations